Carl Zeiss Meditec Ag (CZMWF) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, ladies and gentlemen, and welcome to the Carl Zeiss Meditech follow-up call regarding the CEO change announcement. At this time, all participants have been placed on a listen-only mode. The floor will be open for questions following the presentation. Let me now turn the floor over to your host, Sebastian Frerichs, Head of Investor Relations. Welcome, good morning, and thank you for joining this short notice call. I'm Sebastian, I'm the Head of IR at Carl Zeiss Meditech. For our US-based investors and also our UK investors, whom it is quite early today, a replay and transcript of the call will be made available quickly after we conclude here. Surely all of you have read our news yesterday afternoon regarding the CEO change. With today's call, it is our goal to provide to you an outlook on how we intend to move forward in the short-term, mid-term with management, as well as look on how we expect to achieve continuity in strategy in the future. With no further ado, let me hand it over first to our CFO, Justus. In just a moment, we will also have Andreas, CEO of ZEISS Group, and our designated interim CEO as of January 1st make some comments on the situation. Afterwards, both will be available for some questions. Please note that this call will have to be concluded after about 30 to 40 minutes, so I will kindly ask you to keep questions short and to the point of the CEO change. We will not answer business questions today. These will be covered in depth in our analyst conference in Frankfurt on Thursday, in just a couple of days. So over to you, Justus. Thank you, Sebastian, and also from my side, I'm really appreciating that you took on this short notice the time to join this call. You will all have read the news that our CEO, Maximilian First, is stepping ...